More than a quarter of women who have breast lesions categorized as BI-RADS...Read more on AuntMinnie.comRelated Reading: DBT decreases the need for short-term follow-up CEUS helps reduce unnecessary breast biopsies Elastography methods reduce unnecessary breast biopsies AI may help reduce overdiagnosis of breast cancer ARRS: Is follow-up breast MRI OK for BI-RADS 3 cases? (Source: AuntMinnie.com Headlines)
Tue Oct 29, 2019 14:18
Pharmaceutical company also reports boost from vaccine targeting human papillomarivus (Source: FT.com - Drugs and Healthcare)
Tue Oct 29, 2019 12:57
N1177 provides greater diagnostic efficacy with lower toxicity to cancer patient.(PRWeb October 29, 2019)Read the full story at https://www.prweb.com/releases/nanoscan_imaging_llc_nanoscan_announced_the_sale_of_its_inventory_of_n1177_iodinated_nanoparticulate_and_potential_impact_in_oncology_diagnostics/prweb16678177.htm (Source: PRWeb: Medical Pharmaceuticals)
Tue Oct 29, 2019 01:00
This is a departure from the existing mechanism in which all essential medicines automatically go under price control. The Standing National Committee will decide which medicines should be available in adequate numbers and assured quality. (Source: The Economic Times Healthcare and Biotech News)
Tue Oct 29, 2019 00:00
GPs should order more chest X-rays, encourage bowel cancer screening and trust their gut instincts, if they want to catch cancers at an earlier stage, the RCGP's annual conference was told.Medscape News UK (Source: Medscape FamilyMedicine Headlines)
Fri Oct 25, 2019 13:39
Condition: Breast Cancer Intervention: Drug: Onapristone Sponsor: SOLTI Breast Cancer Research Group Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Tue Oct 29, 2019 17:00
Condition: Hematological Malignancies Intervention: Sponsors: Tampere University Hospital; Tampere University; University of Eastern Finland Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Conditions: HIV Infection; Human Papillomavirus Infection; Human Papillomavirus-Related Carcinoma Interventions: Other: Cytology Specimen Collection Procedure; Procedure: High Resolution Anoscopy with Biopsy; Other: Laboratory Biomarker Analysis; Procedure: Medical Examination; Procedure: Physical Examination; Other: Questionnaire Administration Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Colorectal Cancer Liver Metastases Interventions: Diagnostic Test: [18-F]- FDG - PET; Procedure: Thermal ablation (TA); Diagnostic Test: PET/CT Scan Sponsor: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion Intervention: Drug: larotrectinib(Vitrakvi, BAY2757556) Sponsor: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Pancreatic Adenocarcinoma Intervention: Sponsors: Van Andel Research Institute; Spectrum Health Hospitals; Mercy Health Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Oncologic Disorders Intervention: Other: Care pathway Sponsors: Ilyse Kenis; Kom Op Tegen Kanker; KU Leuven; University Ghent Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Gastrointestinal Stromal Tumor Interventions: Other: DNA extraction of tumer tissue samples and high-throughput sequencing of small panels; Other: DNA extraction of tumer tissue samples and blood sample and high-throughput sequencing of small panels Sponsors: The First Affiliated Hospital with Nanjing Medical University; Fudan University Recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Breast Cancer Intervention: Other: interview Sponsor: Centre Georges Francois Leclerc Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Tue Oct 29, 2019 17:00
Condition: Metastatic Breast Cancer Intervention: Drug: Metformin Sponsor: Hager salah el din Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Tue Oct 29, 2019 17:00
Conditions: Breast Cancer; Breast Neoplasms; Triple Negative Breast Cancer; HER2-positive Breast Cancer Intervention: Drug: Parsaclisib Sponsors: UNC Lineberger Comprehensive Cancer Center; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Hepatocellular Carcinoma Interventions: Drug: Sorafenib; Procedure: Transarterial chemoembolization Sponsor: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Conditions: Chronic Disease; Diabetes; Vascular Diseases; Chronic Lung Disease; Cancer; Psychiatric Disorder Intervention: Device: Telemedicine: tablet and possibly tools to perform measurements Sponsors: University of Oslo; Oslo Economics; Norwegian Centre for Rural Medicine; Norsk Gallup Institutt AS Recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Conditions: Stage IV Non-small Cell Lung Cancer; Stage IV Melanoma; Triple Negative Breast Cancer; Renal Cell Carcinoma Stage IV Intervention: Combination Product: ImmunicomAIAC Sponsor: Prof. Gal Markel Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Musculoskeletal Malignancy Interventions: Behavioral: Personalized acceptance-based mindfulness exercise; Behavioral: Brief educational pamphlet Sponsor: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: HIV Infection Interventions: Other: Cytology Specimen Collection Procedure; Other: Laboratory Biomarker Analysis; Procedure: Medical Examination; Procedure: Physical Examination; Procedure: Proctoscopy with Biopsy; Other: Questionnaire Administration Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); Tata Memorial Hospital; Udaan Trust; University of Arkansas Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Squamous Cell Carcinomas Intervention: Other: solar irradiation and biopsies Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Tue Oct 29, 2019 17:00
Condition: Breast Cancer Intervention: Drug: Enzalutamide Sponsor: SOLTI Breast Cancer Research Group Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Tue Oct 29, 2019 17:00
Condition: Secondhand Exposure to Electronic Cigarette Intervention: Behavioral: Exposure to aerosol of electronic cigarette Sponsor: Institut Català d'Oncologia Completed (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Conditions: Metastatic Cancer; Advanced Cancer; Cancers That Cannot be Treated With Curative Intent Interventions: Genetic: Initiation of POG-related WGTA; Genetic: Usual care Sponsors: British Columbia Cancer Agency; BC Cancer Foundation; Genome British Columbia Active, not recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Condition: Gallbladder Neoplasms Intervention: Sponsors: Shanghai Jiao Tong University School of Medicine; The First Affiliated Hospital of Anhui Medical University; Anhui Provincial Hospital; First Affiliated Hospital Bengbu Medical College; LanZhou University; Henan Cancer Hospital; The First Affiliated Hospital of Zhengzhou University; The Second Affiliated Hospital of Harbin Medical University; First Affiliated Hospital of Harbin Medical University; Harbin Medical University;...
Mon Oct 28, 2019 17:00
Conditions: Neoplasms; Hiv; Cervical Cancer; Breast Cancer; HNSCC; Vulvar Cancer; Anal Cancer; Cancer Suspect Interventions: Other: Potlako intervention; Other: Enhanced care Sponsors: Brigham and Women's Hospital; Botswana Harvard Aids Institute; Dana-Farber Cancer Institute; National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey; University of Oxford Not yet recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Conditions: Oligometastasis; Prostate Cancer Intervention: Radiation: local ablative radiotherapy Sponsor: Technische Universität Dresden Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Mon Oct 28, 2019 17:00
Conditions: Non Small Cell Lung Cancer; Advanced Solid Tumor; Metastatic Melanoma; Metastatic Head and Neck Carcinoma; Metastatic Renal Cell Carcinoma; Metastatic Colorectal Cancer; Sarcomas; Metastatic Prostate Cancer Interventions: Drug: ONC-392; Drug: Pembrolizumab Sponsor: OncoImmune, Inc. Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best...
Mon Oct 28, 2019 17:00
Conditions: Pancreas Cancer; Adenocarcinoma of the Pancreas Interventions: Drug: Digoxin; Drug: 5Fluorouracil; Drug: Calcium Leucovorin; Drug: Irinotecan; Drug: Oxaliplatin Sponsors: Jean Grem, MD; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Conditions: Rectal Neoplasms; Colostomy Stoma; Quality of Life Interventions: Procedure: Perineal pseudocontinent colostomy; Procedure: Permanent left iliac colostomy Sponsors: Moroccan Society of Surgery; Institut National d'Oncologie Sidi Mohammed Ben Abdellah Recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Conditions: Bronchoscopy; Lung Cancer; Solitary Pulmonary Nodule Intervention: Device: Archimedes procedure Sponsor: University Hospital, Limoges Not yet recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Conditions: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Locally Advanced Oropharyngeal Squamous Cell Carcinoma; Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVA Oropharyngeal (p16-Negative)...
Mon Oct 28, 2019 17:00
Condition: Passive Exposure to Electronic Cigarette Aerosols Intervention: Other: No intervention Sponsors: Institut Català d'Oncologia; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Stirling; Hellenic Cancer Society; Mario Negri Institute for Pharmacological Research Recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Conditions: Bone Metastases; Thyroid Cancer Interventions: Other: Administrative data; Other: Clinical data; Other: Histological data; Other: Imaging data; Other: Biological data; Other: Further treatment Sponsor: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Mon Oct 28, 2019 17:00
Conditions: Cancer; Genetic Predisposition Intervention: Genetic: blood sample Sponsor: Centre Georges Francois Leclerc Recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Condition: Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder) Interventions: Drug: Ipilimumab; Drug: Osimertinib Sponsor: University of Utah Not yet recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Condition: Breast Cancer Intervention: Other: Virtual reality Sponsor: Yonsei University Not yet recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Conditions: FLT3 Internal Tandem Duplication; FLT3 Tyrosine Kinase Domain Point Mutation; Recurrent Acute Myeloid Leukemia; Recurrent High Risk Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory High Risk Myelodysplastic Syndrome Interventions: Drug: Azacitidine; Drug: Gilteritinib; Drug: Gilteritinib Fumarate; Drug: Venetoclax Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Mon Oct 28, 2019 17:00
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου